{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:14:06Z","timestamp":1794366846003,"version":"4.9.0"},"reference-count":203,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Polyomavirus BK virus (BKPyV) infection is an important complication of kidney transplantation and allograft failure. The prevalence of viremia is 10%\u201315%, compared with BK-associated nephropathy (BKPyVAN) at 3%\u20135%. Given that there are no effective antiviral prophylaxis or treatment strategies for BKPyVAN, active screening to detect BKPyV viremia is recommended, particularly during the early posttransplant period. Immunosuppression reduction to allow viral clearance may avoid progression to severe and irreversible allograft damage. The frequency and duration of screening are highly variable between transplant centers because the evidence is reliant largely on observational data. While the primary treatment goals center on achieving viral clearance through immunosuppression reduction, prevention of subsequent acute rejection, premature graft loss, and return to dialysis remain as major challenges. Treatment strategies for BKPyV infection should be individualized to the recipient\u2019s underlying immunological risk and severity of the allograft infection. Efficacy data for adjuvant therapies including intravenous immunoglobulin and cidofovir are sparse. Future well-powered and high-quality randomized controlled trials are needed to inform evidence-based clinical practice for the management of BKPy infection.<\/jats:p>","DOI":"10.1097\/tp.0000000000003801","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T10:09:57Z","timestamp":1619604597000},"page":"e76-e89","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Polyoma BK Virus in Kidney Transplant Recipients: Screening, Monitoring, and Management"],"prefix":"10.1097","volume":"106","author":[{"given":"Thida Maung","family":"Myint","sequence":"first","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia."},{"name":"Newcastle Transplant Unit, John Hunter Hospital, Newcastle, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanel H. Y.","family":"Chong","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wyld","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Nankivell","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Kable","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia."},{"name":"Department of Renal Medicine, Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia."},{"name":"Centre for Kidney Research, The Children\u2019s Hospital at Westmead, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","article-title":"New human papovavirus (B.K.) isolated from urine after renal transplantation.","volume":"1","author":"Gardner","year":"1971","journal-title":"Lancet"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"e1000363","DOI":"10.1371\/journal.ppat.1000363","article-title":"Seroepidemiology of human polyomaviruses.","volume":"5","author":"Kean","year":"2009","journal-title":"Plos Pathog"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/0-387-32957-9_2","article-title":"Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV).","volume":"577","author":"Knowles","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations.","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 7","key":"R7-20250604","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1469-0691.12538","article-title":"European perspective on human polyomavirus infection, replication and disease in solid organ transplantation.","volume":"20","author":"Hirsch","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/jgv.0.000839","article-title":"ICTV virus taxonomy profile: polyomaviridae.","volume":"98","author":"Moens","year":"2017","journal-title":"J Gen Virol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"E327","DOI":"10.3390\/v9110327","article-title":"Biology of the BKPyV: an update.","volume":"9","author":"Helle","year":"2017","journal-title":"Viruses"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK polyomavirus: clinical aspects, immune regulation, and emerging therapies.","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.02169-08","article-title":"Early events during BK virus entry and disassembly.","volume":"83","author":"Jiang","year":"2009","journal-title":"J Virol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1128\/JVI.02180-08","article-title":"Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis.","volume":"83","author":"Luo","year":"2009","journal-title":"J Virol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmv.1890410104","article-title":"Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products.","volume":"41","author":"Jin","year":"1993","journal-title":"J Med Virol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/JCM.01180-16","article-title":"A simple and reliable strategy for BK virus subtyping and subgrouping.","volume":"55","author":"Morel","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1128\/JVI.00510-06","article-title":"Phylogenetic analysis of polyomavirus BK sequences.","volume":"80","author":"Sharma","year":"2006","journal-title":"J Virol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jebm.12366","article-title":"BK polyomavirus genotypes in renal transplant recipients in the United States: a meta-analysis.","volume":"12","author":"Thongprayoon","year":"2019","journal-title":"J Evid Based Med"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.micinf.2006.11.008","article-title":"Relationships between BK virus lineages and human populations.","volume":"9","author":"Zheng","year":"2007","journal-title":"Microbes Infect"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1099\/vir.0.83611-0","article-title":"Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race.","volume":"90","author":"Zhong","year":"2009","journal-title":"J Gen Virol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1348-0421.2009.00121.x","article-title":"Comparison of the distribution patterns of BK polyomavirus lineages among China, Korea and Japan: implications for human migrations in northeast Asia.","volume":"53","author":"Zhong","year":"2009","journal-title":"Microbiol Immunol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00007890-200204150-00013","article-title":"DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis.","volume":"73","author":"Randhawa","year":"2002","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/rmv.613","article-title":"Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications.","volume":"19","author":"Yogo","year":"2009","journal-title":"Rev Med Virol"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"e2102","DOI":"10.1002\/rmv.2102","article-title":"BK polyomavirus diversity-Why viral variation matters.","volume":"30","author":"Blackard","year":"2020","journal-title":"Rev Med Virol"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20072097","article-title":"Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology.","volume":"205","author":"Gosert","year":"2008","journal-title":"J Exp Med"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.2003.00132.x","article-title":"Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy.","volume":"64","author":"Randhawa","year":"2003","journal-title":"Kidney Int"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcv.2019.02.002","article-title":"The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.","volume":"113","author":"Korth","year":"2019","journal-title":"J Clin Virol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/321813","article-title":"Bk virus: a clinical review.","volume":"33","author":"Reploeg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","article-title":"Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia.","volume":"5","author":"Bohl","year":"2005","journal-title":"Am J Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/infdis\/158.1.176","article-title":"A serological investigation of BK virus and JC virus infections in recipients of renal allografts.","volume":"158","author":"Andrews","year":"1988","journal-title":"J Infect Dis"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/TP.0000000000001066","article-title":"Viral origin, clinical course, and renal outcomes in patients with BK virus infection after living-donor renal transplantation.","volume":"100","author":"Schwarz","year":"2016","journal-title":"Transplantation"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ajt.13880","article-title":"Pretransplantation donor-recipient pair seroreactivity against BK polyomavirus predicts viremia and nephropathy after kidney transplantation.","volume":"17","author":"Wunderink","year":"2017","journal-title":"Am J Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors.","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/JCM.01645-06","article-title":"Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals.","volume":"45","author":"Zhong","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/ajt.13684","article-title":"The \u201cABC\u201d of Virus-Specific T cell immunity in solid organ transplantation.","volume":"16","author":"Sester","year":"2016","journal-title":"Am J Transplant"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/ajt.13252","article-title":"The Loss of BKV-specific immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased risk of BKV replication.","volume":"15","author":"Schachtner","year":"2015","journal-title":"Am J Transplant"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1111\/j.1600-6143.2005.01096.x","article-title":"Molecular evaluation of BK polyomavirus nephropathy.","volume":"5","author":"Mannon","year":"2005","journal-title":"Am J Transplant"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrneph.2011.59","article-title":"BK polyomavirus infection and nephropathy: the virus-immune system interplay.","volume":"7","author":"Babel","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/ajt.14292","article-title":"BK virus nephropathy: histological evolution by sequential pathology.","volume":"17","author":"Nankivell","year":"2017","journal-title":"Am J Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/path.4584","article-title":"The oncogenic potential of BK-polyomavirus is linked to viral integration into the human genome.","volume":"237","author":"Kenan","year":"2015","journal-title":"J Pathol"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bmt.2013.235","article-title":"High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.","volume":"49","author":"Gilis","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2215\/CJN.04051206","article-title":"BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry.","volume":"2","author":"Smith","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00007890-199903270-00022","article-title":"Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss.","volume":"67","author":"Binet","year":"1999","journal-title":"Transplantation"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcv.2018.10.002","article-title":"Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review.","volume":"109","author":"Demey","year":"2018","journal-title":"J Clin Virol"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfn671","article-title":"Risk factors for polyoma virus nephropathy.","volume":"24","author":"Prince","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/ndt\/gfv441","article-title":"Simultaneous pancreas\/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.","volume":"31","author":"Schachtner","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-6143.2004.00685.x","article-title":"BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.","volume":"5","author":"Lipshutz","year":"2005","journal-title":"Am J Transplant"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.trre.2015.02.004","article-title":"The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: a systematic review.","volume":"29","author":"Viswesh","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.TP.0000145057.41418.22","article-title":"Native kidney BK nephropathy post cardiac transplantation.","volume":"79","author":"Menahem","year":"2005","journal-title":"Transplantation"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s12879-020-05292-0","article-title":"BK virus-associated nephropathy in a lung transplant patient: case report and literature review.","volume":"20","author":"Crowhurst","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"310","DOI":"10.12659\/AOT.908429","article-title":"BK virus: a cause for concern in thoracic transplantation?","volume":"23","author":"Barten","year":"2018","journal-title":"Ann Transplant"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2009.01.271","article-title":"Polyomavirus nephropathy: a current perspective and clinical considerations.","volume":"54","author":"Wiseman","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"e12942","DOI":"10.1111\/petr.12942","article-title":"The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: a prospective study.","volume":"21","author":"Verghese","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/infdis\/jiz114","article-title":"Impact of pretransplant donor BK viruria in kidney transplant recipients.","volume":"220","author":"Tan","year":"2019","journal-title":"J Infect Dis"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/TP.0000000000000890","article-title":"Risk factors for BK polyoma virus treatment and association of treatment with kidney transplant failure: insights from a paired kidney analysis.","volume":"100","author":"Thangaraju","year":"2016","journal-title":"Transplantation"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3062.2008.00342.x","article-title":"Prospective monitoring of BK virus replication in renal transplant recipients.","volume":"11","author":"Koukoulaki","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/tid.12347","article-title":"Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.","volume":"17","author":"Tohme","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jfma.2016.01.008","article-title":"Conversion to mTOR-inhibitors with calcineurin inhibitor elimination or minimization reduces urinary polyomavirus BK load in kidney transplant recipients.","volume":"115","author":"Yen","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"e13265","DOI":"10.1111\/ctr.13265","article-title":"Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.","volume":"32","author":"Knight","year":"2018","journal-title":"Clin Transplant"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States.","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/tid.12135","article-title":"Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy.","volume":"15","author":"Chung","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"R63-20250604","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.TP.0000437671.78716.f3","article-title":"Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab.","volume":"97","author":"Barbosa","year":"2014","journal-title":"Transplantation"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/01.TP.0000061597.09830.49","article-title":"Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients.","volume":"75","author":"Haririan","year":"2003","journal-title":"Transplantation"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring.","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/s41598-017-02140-1","article-title":"Tacrolimus blood level fluctuation predisposes to coexisting BK virus nephropathy and acute allograft rejection.","volume":"7","author":"Shen","year":"2017","journal-title":"Sci Rep"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1399-0012.2004.00191.x","article-title":"Risk factors for BK polyomavirus nephritis in renal allograft recipients.","volume":"18","author":"Rocha","year":"2004","journal-title":"Clin Transplant"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-6143.2012.04314.x","article-title":"BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation.","volume":"13","author":"Theodoropoulos","year":"2013","journal-title":"Am J Transplant"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5002247","article-title":"Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender.","volume":"71","author":"Khamash","year":"2007","journal-title":"Kidney Int"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/tri.12888","article-title":"Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation.","volume":"30","author":"Maliakkal","year":"2017","journal-title":"Transpl Int"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1399-3062.2003.00009.x","article-title":"Polyomavirus in kidney and kidney-pancreas transplant recipients.","volume":"5","author":"Trofe","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"e12974","DOI":"10.1111\/tid.12974","article-title":"Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes.","volume":"20","author":"Plafkin","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.transproceed.2009.01.036","article-title":"Reactivation of BK virus in the early period after kidney transplantation.","volume":"41","author":"Ziedina","year":"2009","journal-title":"Transplant Proc"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.transproceed.2015.08.006","article-title":"Risk factors for the development of BK virus nephropathy in renal transplant recipients.","volume":"47","author":"Pai","year":"2015","journal-title":"Transplant Proc"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1399-3046.2011.01583.x","article-title":"Pretransplant serologic testing to identify the risk of polyoma BK viremia in pediatric kidney transplant recipients.","volume":"15","author":"Ali","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.tp.0000269616.21698.10","article-title":"Ureteral stents: a novel risk factor for polyomavirus nephropathy.","volume":"84","author":"Thomas","year":"2007","journal-title":"Transplantation"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.transproceed.2014.08.036","article-title":"Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction.","volume":"46","author":"Huang","year":"2014","journal-title":"Transplant Proc"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.transproceed.2017.01.009","article-title":"Prevalence and risk factors of BK viremia in patients with kidney transplantation: a single-center experience from Turkey.","volume":"49","author":"Dogan","year":"2017","journal-title":"Transplant Proc"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5527\/wjn.v5.i6.497","article-title":"Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012.","volume":"5","author":"Hsiao","year":"2016","journal-title":"World J Nephrol"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.transproceed.2011.06.034","article-title":"Ureteral stents: a risk factor for polyomavirus BK viremia in kidney transplant recipients undergoing protocol screening.","volume":"43","author":"Siparsky","year":"2011","journal-title":"Transplant Proc"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tid.12051","article-title":"Ureteral stent placement and BK viremia in kidney transplant recipients.","volume":"15","author":"Kayler","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"459747","DOI":"10.1155\/2014\/459747","article-title":"Ureteral stent placement increases the risk for developing BK viremia after kidney transplantation.","volume":"2014","author":"Hashim","year":"2014","journal-title":"J Transplant"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"e12644","DOI":"10.1111\/tid.12644","article-title":"Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation.","volume":"19","author":"Wingate","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R84-20250604","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.transproceed.2014.11.049","article-title":"How to reduce lethal infectious complications in ABO-incompatible kidney transplantation.","volume":"47","author":"Choi","year":"2015","journal-title":"Transplant Proc"},{"key":"R85-20250604","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1600-6143.2004.00563.x","article-title":"HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients.","volume":"4","author":"Awadalla","year":"2004","journal-title":"Am J Transplant"},{"key":"R86-20250604","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/tid.12153","article-title":"Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.","volume":"16","author":"H\u00e4ssig","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R87-20250604","doi-asserted-by":"crossref","first-page":"E847","DOI":"10.3390\/cells8080847","article-title":"HLA-E polymorphism determines susceptibility to BK virus nephropathy after living-donor kidney transplant.","volume":"8","author":"Rohn","year":"2019","journal-title":"Cells"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/TP.0000000000002376","article-title":"Reduced risk of BK polyomavirus infection in HLA-B51-positive kidney transplant recipients.","volume":"103","author":"Wunderink","year":"2019","journal-title":"Transplantation"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.TP.0000165096.01034.15","article-title":"Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy.","volume":"80","author":"Drachenberg","year":"2005","journal-title":"Transplantation"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/ndt\/gft298","article-title":"HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.","volume":"28","author":"Masutani","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"R91-20250604","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/tan.13645","article-title":"Combined association of recipient killer cell immunoglobulin-like haplotype AA and donor HLA-C*07 gene with BK virus associated nephropathy in kidney transplant patients.","volume":"94","author":"Kovacevic Vojtusek","year":"2019","journal-title":"HLA"},{"key":"R92-20250604","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ebiom.2018.07.017","article-title":"BKV, CMV, and EBV Interactions and their effect on graft function one year post-renal transplantation: results from a large multi-centre Study.","volume":"34","author":"Blazquez-Navarro","year":"2018","journal-title":"Ebiomedicine"},{"key":"R93-20250604","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1046\/j.1600-6143.2004.00603.x","article-title":"Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load.","volume":"4","author":"Drachenberg","year":"2004","journal-title":"Am J Transplant"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/j.1600-6143.2005.00988.x","article-title":"Safety and adequacy of renal transplant protocol biopsies.","volume":"5","author":"Schwarz","year":"2005","journal-title":"Am J Transplant"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1681\/ASN.2017050477","article-title":"The Banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations.","volume":"29","author":"Nickeleit","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2214\/AJR.10.4427","article-title":"Imaging-guided percutaneous renal biopsy: rationale and approach.","volume":"194","author":"Uppot","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"R97-20250604","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1001\/jama.2014.14721","article-title":"Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial.","volume":"312","author":"Knoll","year":"2014","journal-title":"JAMA"},{"key":"R98-20250604","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"R99-20250604","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/sur.2008.052","article-title":"Monthly screening for polyoma virus eliminates BK nephropathy and preserves renal function.","volume":"10","author":"Petrov","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"R100-20250604","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy.","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"key":"R101-20250604","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tri.12134","article-title":"The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.","volume":"26","author":"Elfadawy","year":"2013","journal-title":"Transpl Int"},{"key":"R102-20250604","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5500\/wjt.v7.i5.269","article-title":"Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia.","volume":"7","author":"Azar","year":"2017","journal-title":"World J Transplant"},{"key":"R103-20250604","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.transproceed.2020.01.158","article-title":"Clinical characteristic and outcomes of BK virus infection in kidney transplant recipients managed using a systematic surveillance and treatment strategy.","volume":"52","author":"Lee","year":"2020","journal-title":"Transplant Proc"},{"key":"R104-20250604","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"R105-20250604","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2010.05.004","article-title":"Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.","volume":"56","author":"Knoll","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R106-20250604","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1440-1797.2011.01559.x","article-title":"KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients.","volume":"17","author":"Chadban","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"R107-20250604","doi-asserted-by":"crossref","first-page":"e13672","DOI":"10.1111\/ctr.13672","article-title":"Screening for BK polyomavirus DNAemia: what should be done?","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"key":"R108-20250604","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.ekir.2020.06.038","article-title":"Screening and management practices for polyoma (BK) viremia and nephropathy in kidney transplant recipients from the lands down under: addressing the unknowns and rationale for a multicenter Clinical Trial.","volume":"5","author":"Wong","year":"2020","journal-title":"Kidney Int Rep"},{"key":"R109-20250604","doi-asserted-by":"crossref","first-page":"e12985","DOI":"10.1111\/tid.12985","article-title":"New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines.","volume":"20","author":"Gabardi","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"R110-20250604","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/tri.12602","article-title":"BK virus screening and management practices among US renal transplant programs: a survey.","volume":"28","author":"Hodowanec","year":"2015","journal-title":"Transpl Int"},{"key":"R111-20250604","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ndt\/gfv392","article-title":"Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.","volume":"31","author":"Pape","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"R112-20250604","doi-asserted-by":"crossref","first-page":"235","DOI":"10.21037\/atm.2020.01.15","article-title":"Non-invasive urinary sediment double-immunostaining predicts BK polyomavirus associated-nephropathy in kidney transplant recipients.","volume":"8","author":"Chen","year":"2020","journal-title":"Ann Transl Med"},{"key":"R113-20250604","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.transproceed.2020.01.044","article-title":"Sternheimer-malbin staining to detect decoy cells in urine of 213 kidney transplant patients.","volume":"52","author":"Yan","year":"2020","journal-title":"Transplant Proc"},{"key":"R114-20250604","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/TP.0000000000000642","article-title":"Clinical utility of urinary cytology to detect BK viral nephropathy.","volume":"99","author":"Nankivell","year":"2015","journal-title":"Transplantation"},{"key":"R115-20250604","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1681\/ASN.2008010117","article-title":"Presence of urinary Haufen accurately predicts polyomavirus nephropathy.","volume":"20","author":"Singh","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R116-20250604","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJM200005043421802","article-title":"Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.","volume":"342","author":"Nickeleit","year":"2000","journal-title":"N Engl J Med"},{"key":"R117-20250604","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/JCM.00258-08","article-title":"Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays.","volume":"46","author":"Hoffman","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R118-20250604","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JCM.02145-15","article-title":"Sequence variation in amplification target genes and standards influences interlaboratory comparison of BK virus DNA load measurement.","volume":"53","author":"Solis","year":"2015","journal-title":"J Clin Microbiol"},{"key":"R119-20250604","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/JCM.01230-11","article-title":"Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection.","volume":"49","author":"Randhawa","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R120-20250604","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00007890-200208270-00009","article-title":"Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy.","volume":"74","author":"Randhawa","year":"2002","journal-title":"Transplantation"},{"key":"R121-20250604","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.diagmicrobio.2006.08.006","article-title":"Quantification and identification of polyomavirus DNA in blood and urine of renal transplant recipients.","volume":"57","author":"Baldanti","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R122-20250604","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.tp.0000275205.41078.51","article-title":"Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy.","volume":"84","author":"Viscount","year":"2007","journal-title":"Transplantation"},{"key":"R123-20250604","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3346\/jkms.2008.23.5.814","article-title":"Quantitation of BK virus DNA for diagnosis of BK virus-associated nephropathy in renal transplant recipients.","volume":"23","author":"Sung","year":"2008","journal-title":"J Korean Med Sci"},{"key":"R124-20250604","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1093\/ndt\/gfn289","article-title":"Monitoring of BK virus replication in the first year following renal transplantation.","volume":"23","author":"Costa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R125-20250604","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/TP.0b013e3181aa8f62","article-title":"Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples.","volume":"88","author":"Babel","year":"2009","journal-title":"Transplantation"},{"key":"R126-20250604","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcv.2009.05.025","article-title":"Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement.","volume":"45","author":"Boudreault","year":"2009","journal-title":"J Clin Virol"},{"key":"R127-20250604","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1440-1797.2009.01118.x","article-title":"Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipients.","volume":"14","author":"Cross","year":"2009","journal-title":"Nephrology"},{"key":"R128-20250604","first-page":"165","article-title":"Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN.","volume":"34","author":"Pollara","year":"2011","journal-title":"New Microbiol"},{"key":"R129-20250604","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jmv.22106","article-title":"A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients.","volume":"83","author":"Girmanova","year":"2011","journal-title":"J Med Virol"},{"key":"R130-20250604","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1432-2277.2012.01480.x","article-title":"Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy.","volume":"25","author":"Chung","year":"2012","journal-title":"Transpl Int"},{"key":"R131-20250604","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diagmicrobio.2012.11.012","article-title":"Noninvasive tool for the diagnosis of polyomavirus BK-associated nephropathy in renal transplant recipients.","volume":"75","author":"Huang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R132-20250604","doi-asserted-by":"crossref","first-page":"E571","DOI":"10.1111\/ctr.12195","article-title":"Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients.","volume":"27","author":"Myint","year":"2013","journal-title":"Clin Transplant"},{"key":"R133-20250604","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1111\/ctr.12048","article-title":"Detection of BK polyomavirus after kidney transplantation: a comparison of urine electron microscopy with plasma polymerase chain reaction.","volume":"27","author":"Westervelt","year":"2013","journal-title":"Clin Transplant"},{"key":"R134-20250604","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/tid.12164","article-title":"Currently recommended BK virus (BKV) plasma viral load cutoff of \u22654 log10\/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.","volume":"16","author":"Hassan","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R135-20250604","first-page":"455","article-title":"Clinical validation study of quantitative real-time PCR assay for detection and monitoring of BK virus nephropathy.","volume":"44","author":"Kudose","year":"2014","journal-title":"Ann Clin Lab Sci"},{"key":"R136-20250604","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000443514","article-title":"Screening algorithm for BK virus-associated nephropathy using sequential testing of urinary cytology: a probabilistic model analysis.","volume":"42","author":"Ma","year":"2015","journal-title":"Am J Nephrol"},{"key":"R137-20250604","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12879-016-1652-6","article-title":"Optimal use of plasma and urine BK viral loads for screening and predicting BK nephropathy.","volume":"16","author":"Boan","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R138-20250604","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biologicals.2019.04.004","article-title":"The development and establishment of the 1st WHO BKV International Standard for nucleic acid based techniques.","volume":"60","author":"Govind","year":"2019","journal-title":"Biologicals"},{"key":"R139-20250604","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JCM.02315-16","article-title":"Calibration of BK virus nucleic acid amplification testing to the 1st WHO international standard for BK Virus.","volume":"55","author":"Tan","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R140-20250604","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1373\/clinchem.2016.265512","article-title":"Quantification of BK virus standards by quantitative real-time PCR and droplet digital PCR is confounded by multiple virus populations in the WHO BKV international standard.","volume":"63","author":"Bateman","year":"2017","journal-title":"Clin Chem"},{"key":"R141-20250604","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.idc.2018.04.009","article-title":"Management of BK polyomavirus infection in kidney and kidney-pancreas transplant recipients: a review article.","volume":"32","author":"Elfadawy","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"R142-20250604","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/JCM.00655-07","article-title":"Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study.","volume":"45","author":"Pang","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R143-20250604","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1399-3046.2010.01318.x","article-title":"Cost-efficient screening for BK virus in pediatric kidney transplantation: a single-center experience and review of the literature.","volume":"14","author":"Laskin","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R144-20250604","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00007890-200210150-00016","article-title":"Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine.","volume":"74","author":"Ding","year":"2002","journal-title":"Transplantation"},{"key":"R145-20250604","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.krcp.2016.05.005","article-title":"High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients.","volume":"35","author":"Chon","year":"2016","journal-title":"Kidney Res Clin Pract"},{"key":"R146-20250604","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.TP.0000061767.32870.72","article-title":"Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches.","volume":"75","author":"Ginevri","year":"2003","journal-title":"Transplantation"},{"key":"R147-20250604","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcv.2008.06.009","article-title":"BK virus antibody titers and intensity of infections after renal transplantation.","volume":"43","author":"Bohl","year":"2008","journal-title":"J Clin Virol"},{"key":"R148-20250604","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.13001213","article-title":"Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?","volume":"9","author":"Anwar","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R149-20250604","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.transproceed.2006.08.067","article-title":"Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy.","volume":"38","author":"Lopez","year":"2006","journal-title":"Transplant Proc"},{"key":"R150-20250604","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.kjms.2016.01.004","article-title":"Fluoroquinolone prophylaxis in preventing BK polyomavirus infection after renal transplant: A systematic review and meta-analysis.","volume":"32","author":"Song","year":"2016","journal-title":"Kaohsiung J Med Sci"},{"key":"R151-20250604","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","article-title":"Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.","volume":"34","author":"Bischof","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"R152-20250604","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2215\/CJN.04080318","article-title":"BK virus nephropathy.","volume":"13","author":"Sawinski","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R153-20250604","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/tri.13392","article-title":"No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.","volume":"32","author":"Devresse","year":"2019","journal-title":"Transpl Int"},{"key":"R154-20250604","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2215\/CJN.05691207","article-title":"Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies.","volume":"3","author":"Weiss","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R155-20250604","doi-asserted-by":"crossref","first-page":"e13194","DOI":"10.1111\/ctr.13194","article-title":"De novo donor-specific antibody following BK nephropathy: the incidence and association with antibody-mediated rejection.","volume":"32","author":"Cheungpasitporn","year":"2018","journal-title":"Clin Transplant"},{"key":"R156-20250604","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.transproceed.2019.03.061","article-title":"Clinical significance of mycophenolate mofetil withdrawal in kidney transplant recipients.","volume":"51","author":"Park","year":"2019","journal-title":"Transplant Proc"},{"key":"R157-20250604","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/TP.0b013e318166cba8","article-title":"Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.","volume":"85","author":"Saad","year":"2008","journal-title":"Transplantation"},{"key":"R158-20250604","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ajt.13541","article-title":"BK polyomavirus replication in renal tubular epithelial cells is inhibited by sirolimus, but activated by tacrolimus through a pathway involving FKBP-12.","volume":"16","author":"Hirsch","year":"2016","journal-title":"Am J Transplant"},{"key":"R159-20250604","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation.","volume":"29","author":"Pascual","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R160-20250604","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/ajt.15480","article-title":"Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.","volume":"19","author":"Berger","year":"2019","journal-title":"Am J Transplant"},{"key":"R161-20250604","first-page":"CD004290","article-title":"Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.","volume":"12","author":"Hahn","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R162-20250604","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2215\/CJN.13221216","article-title":"CMV and BKPyV Infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: a systematic review and meta-analysis of randomized, Controlled Trials.","volume":"12","author":"Mallat","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R163-20250604","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin.","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant Direct"},{"key":"R164-20250604","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ajt.13083","article-title":"Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.","volume":"15","author":"Randhawa","year":"2015","journal-title":"Am J Transplant"},{"key":"R165-20250604","doi-asserted-by":"crossref","first-page":"e00393","DOI":"10.1128\/AAC.00393-19","article-title":"Intravenous immunoglobulin administration significantly increases BKPyV genotype-specific neutralizing antibody titers in kidney transplant recipients.","volume":"63","author":"Velay","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"R166-20250604","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1111\/j.1399-3046.2010.01384.x","article-title":"Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients.","volume":"16","author":"Anyaegbu","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R167-20250604","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant Proc"},{"key":"R168-20250604","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients.","volume":"81","author":"Sener","year":"2006","journal-title":"Transplantation"},{"key":"R169-20250604","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/TCRM.S273388","article-title":"Clinical efficacy of intravenous immunoglobulin for BK polyomavirus-associated nephropathy after living kidney transplantation.","volume":"16","author":"Matsumura","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"R170-20250604","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.tp.0000181149.76113.50","article-title":"Treatment of renal allograft polyoma BK virus infection with leflunomide.","volume":"81","author":"Josephson","year":"2006","journal-title":"Transplantation"},{"key":"R171-20250604","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1432-2277.2007.00523.x","article-title":"Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.","volume":"20","author":"Faguer","year":"2007","journal-title":"Transpl Int"},{"key":"R172-20250604","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.intimp.2009.05.004","article-title":"Polyoma BK virus-associated nephropathy in kidney-transplant patients: effects of leflunomide on T-cell functions and disease outcome.","volume":"9","author":"Canivet","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"R173-20250604","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.TP.0000441825.72639.4f","article-title":"A novel treatment regimen for BK viremia.","volume":"97","author":"Zaman","year":"2014","journal-title":"Transplantation"},{"key":"R174-20250604","doi-asserted-by":"crossref","first-page":"e13058","DOI":"10.1111\/tid.13058","article-title":"Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: a multicenter retrospective study.","volume":"21","author":"Keller","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"R175-20250604","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.transproceed.2019.03.035","article-title":"Prevalence, risk factors, treatment, and overall impact of BK viremia on kidney transplantation.","volume":"51","author":"Malik","year":"2019","journal-title":"Transplant Proc"},{"key":"R176-20250604","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1440-1797.2008.00214.x","article-title":"Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.","volume":"8","author":"Lim","year":"2003","journal-title":"Nephrology (Carlton)"},{"key":"R177-20250604","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1399-3046.2008.00937.x","article-title":"Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy.","volume":"12","author":"Araya","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R178-20250604","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.transproceed.2008.09.002","article-title":"Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.","volume":"40","author":"Cabello","year":"2008","journal-title":"Transplant Proc"},{"key":"R179-20250604","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ndt\/gfn675","article-title":"The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.","volume":"24","author":"Wu","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R180-20250604","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jac\/dkn495","article-title":"A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.","volume":"63","author":"Kuypers","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R181-20250604","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/tid.12313","article-title":"Observations on the use of cidofovir for BK virus infection in renal transplantation.","volume":"16","author":"Kuten","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R182-20250604","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/JVI.01737-09","article-title":"Leflunomide inhibition of BK virus replication in renal tubular epithelial cells.","volume":"84","author":"Bernhoff","year":"2010","journal-title":"J Virol"},{"key":"R183-20250604","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2215\/CJN.04230413","article-title":"Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.","volume":"9","author":"Lee","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R184-20250604","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15171\/jnp.2016.06","article-title":"Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience.","volume":"5","author":"Nesselhauf","year":"2016","journal-title":"J Nephropathol"},{"key":"R185-20250604","first-page":"58","article-title":"Long-term follow-up of active treatment versus minimization of immunosuppressive agents in patients with BK virus-associated nephropathy after kidney transplant.","volume":"14","author":"Halim","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"R186-20250604","doi-asserted-by":"crossref","first-page":"100565","DOI":"10.1016\/j.trre.2020.100565","article-title":"Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients - A systematic review.","volume":"34","author":"Schneidewind","year":"2020","journal-title":"Transplant Rev (Orlando)"},{"key":"R187-20250604","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1600-6143.2008.02269.x","article-title":"Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression.","volume":"8","author":"Bernhoff","year":"2008","journal-title":"Am J Transplant"},{"key":"R188-20250604","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.TP.0000149338.97084.5F","article-title":"Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system.","volume":"79","author":"Farasati","year":"2005","journal-title":"Transplantation"},{"key":"R189-20250604","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/ndt\/17.11.2023","article-title":"Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.","volume":"17","author":"Bjorang","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R190-20250604","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1600-6143.2005.00980.x","article-title":"Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.","volume":"5","author":"Kuypers","year":"2005","journal-title":"Am J Transplant"},{"key":"R191-20250604","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/TP.0b013e31823e7b0e","article-title":"Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.","volume":"93","author":"Hua","year":"2012","journal-title":"Transplantation"},{"key":"R192-20250604","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/tid.12467","article-title":"Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.","volume":"17","author":"Dieplinger","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"R193-20250604","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"R194-20250604","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TP.0000000000000869","article-title":"The influence of immunosuppressive agents on the risk of de novo donor-specific HLA antibody production in solid organ transplant recipients.","volume":"100","author":"O\u2019Leary","year":"2016","journal-title":"Transplantation"},{"key":"R195-20250604","doi-asserted-by":"crossref","first-page":"e13472","DOI":"10.1111\/tid.13472","article-title":"Increasing net immunosuppression after BK polyoma virus infection.","volume":"23","author":"Cotiguala","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R196-20250604","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ajt.15723","article-title":"Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents.","volume":"20","author":"Leeaphorn","year":"2020","journal-title":"Am J Transplant"},{"key":"R197-20250604","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/TP.0b013e3181dcfe52","article-title":"Preemptive retransplant for BK virus nephropathy without concurrent transplant nephrectomy.","volume":"90","author":"Cooper","year":"2010","journal-title":"Transplantation"},{"key":"R198-20250604","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40620-015-0200-6","article-title":"Kidney retransplantation for BK virus nephropathy with active viremia without allograft nephrectomy.","volume":"28","author":"Huang","year":"2015","journal-title":"J Nephrol"},{"key":"R199-20250604","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jcyt.2017.08.011","article-title":"T cell therapies for human polyomavirus diseases.","volume":"19","author":"Davies","year":"2017","journal-title":"Cytotherapy"},{"key":"R200-20250604","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"Suppl 1","key":"R201-20250604","first-page":"S4","article-title":"Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation.","volume":"3","author":"Maecker-Kolhoff","year":"2015","journal-title":"Ann Transl Med"},{"key":"R202-20250604","first-page":"5745","article-title":"Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients.","volume":"4","author":"Nelson","year":"2020","journal-title":"Blood Adv"},{"key":"R203-20250604","doi-asserted-by":"crossref","first-page":"104778","DOI":"10.1016\/j.antiviral.2020.104778","article-title":"Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade.","volume":"178","author":"Panou","year":"2020","journal-title":"Antiviral Res"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:24:19Z","timestamp":1749065059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":203,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003801","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}